EP3826642
EMPAGLIFLOZIN FOR USE IN TREATING ALPORT SYNDROME
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.7.2019EP published:
7.5.2025EP application number:
19742218.1
EPO information:
European Patent Register
Max expiry date:
22.7.2039
Title in English:
EMPAGLIFLOZIN FOR USE IN TREATING ALPORT SYNDROMELanguage of the patent:
English
Timeline
Today
23.7.2019EP application
7.5.2025EP Publication
Owner
Name:
Boehringer Ingelheim International GmbHAddress:
Binger Strasse 173, 55216 Ingelheim am Rhein, DE
Inventor
Name:
VON EYNATTEN, MaximilianAddress:
55216 INGELHEIM AM RHEIN, DE
Name:
GROSS, OliverAddress:
37085 GOETTINGEN, DE
Name:
HAUSKE, Sibylle, JennyAddress:
55216 INGELHEIM AM RHEIN, DE
Priority
Number:
18185598Date:
25.7.2018Country:
EP
Classification
Categories:
A61K 31/7048, A61K 31/55, A61K 45/06, A61P 13/12, A61P 43/00, A61K 9/20